ZORYVE® IT
RELIEVE IT
ANYWHERE
ZORYVE treats it, wherever patients
need it,
with an easy, once-daily,
steroid-free topical1,2
NOW AVAILABLE
CREAM 0.15% FOR
ATOPIC DERMATITIS

DOWN TO 6 YEARS OLD

FOAM 0.3% FOR
SEBORRHEIC DERMATITIS

DOWN TO 9 YEARS OLD

CREAM 0.3% FOR
PLAQUE PSORIASIS

DOWN TO 6 YEARS OLD

ZORYVE® (roflumilast) is a once-daily and steroid-free prescription topical

Symptoms illustrated.
Not actual patients.

ZORYVE (roflumilast) cream 0.15%, ZORYVE (roflumilast) foam 0.3% and ZORYVE (roflumilast) cream 0.3%
Rapid, reliable
results anywhere1-4
Consistently well tolerated
and safe1,2,5
Patient-friendly cream and foam formulations
for easy, long-term disease control1,2,6-8

ATOPIC DERMATITIS: 31% of patients achieved vIGA-AD Success at Week 4, some as early as Week 1.
32% of patients achieved WI-NRS Success at Week 4, with results observed within 24 hours.9,10

SEBORRHEIC DERMATITIS: 77% of patients achieved IGA Success at Week 8, some as early as Week 2.2,9

PLAQUE PSORIASIS: 40% of patients achieved IGA Success at Week 8, some as early as Week 4.1,11

See the study design below and data on respective efficacy pages.